Harvard Bioscience, Inc. (HBIO)
NASDAQ: HBIO · IEX Real-Time Price · USD
2.790
+0.010 (0.36%)
Jul 2, 2024, 4:00 PM EDT - Market closed
Harvard Bioscience Revenue
Harvard Bioscience had revenue of $106.79M in the twelve months ending March 31, 2024, down -6.76% year-over-year. Revenue in the quarter ending March 31, 2024 was $24.51M, a -18.23% decrease year-over-year. In the year 2023, Harvard Bioscience had annual revenue of $112.25M, a decrease of -0.96%.
Revenue (ttm)
$106.79M
Revenue Growth
-6.76%
P/S Ratio
1.13
Revenue / Employee
$273,113
Employees
391
Market Cap
121.17M USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 112.25M | -1.09M | -0.96% |
Dec 31, 2022 | 113.34M | -5.57M | -4.68% |
Dec 31, 2021 | 118.90M | 16.80M | 16.46% |
Dec 31, 2020 | 102.10M | -14.08M | -12.12% |
Dec 31, 2019 | 116.18M | -4.60M | -3.81% |
Dec 31, 2018 | 120.77M | 43.37M | 56.02% |
Dec 31, 2017 | 77.41M | -27.11M | -25.94% |
Dec 31, 2016 | 104.52M | -4.14M | -3.81% |
Dec 31, 2015 | 108.66M | 1,000.00 | 0.00% |
Dec 31, 2014 | 108.66M | 3.49M | 3.32% |
Dec 31, 2013 | 105.17M | -6.00M | -5.40% |
Dec 31, 2012 | 111.17M | 2.31M | 2.12% |
Dec 31, 2011 | 108.86M | 685.00K | 0.63% |
Dec 31, 2010 | 108.18M | 22.41M | 26.12% |
Dec 31, 2009 | 85.77M | -2.28M | -2.59% |
Dec 31, 2008 | 88.05M | 4.64M | 5.57% |
Dec 31, 2007 | 83.41M | 7.23M | 9.49% |
Dec 31, 2006 | 76.18M | 8.75M | 12.98% |
Dec 31, 2005 | 67.43M | 2.69M | 4.15% |
Dec 31, 2004 | 64.75M | 12.72M | 24.45% |
Dec 31, 2003 | 52.02M | -5.36M | -9.33% |
Dec 31, 2002 | 57.38M | 16.51M | 40.40% |
Dec 31, 2001 | 40.87M | 10.29M | 33.67% |
Dec 31, 2000 | 30.57M | 4.40M | 16.80% |
Dec 31, 1999 | 26.18M | 14.02M | 115.38% |
Dec 31, 1998 | 12.15M | 689.87K | 6.02% |
Dec 31, 1997 | 11.46M | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Amylyx Pharmaceuticals | 398.00M |
Assertio Holdings | 142.05M |
Cellectis | 12.13M |
Omega Therapeutics | 4.94M |
I-Mab | 3.90M |
HBIO News
- 26 days ago - Harvard Bioscience, Inc. to Present and Host One-on-One Meetings at the 14th Annual East Coast IDEAS Conference on June 12, 2024 - GlobeNewsWire
- 5 weeks ago - Harvard Bioscience, Inc. to Present at the Jefferies Global Healthcare Conference on June 5, 2024 - GlobeNewsWire
- 6 weeks ago - Harvard Bioscience, Inc. to Participate in the Benchmark Healthcare House Call Virtual Conference - GlobeNewsWire
- 2 months ago - Harvard Bioscience Announces First Quarter 2024 Financial Results - GlobeNewsWire
- 2 months ago - Harvard Bioscience Schedules First Quarter 2024 Earnings Conference Call for May 7, 2024 at 8:00 AM ET - GlobeNewsWire
- 3 months ago - Harvard Bioscience Announces Action to Improve Operational Efficiency and Support Ongoing Investments in Growth - GlobeNewsWire
- 4 months ago - Harvard Bioscience, Inc. to Participate in March 2024 Investor Conferences: Sidoti's Small Cap Conference and KeyBanc's Life Sciences & MedTech Conference - GlobeNewsWire
- 4 months ago - Harvard Bioscience Announces Fourth Quarter 2023 Financial Results - GlobeNewsWire